Literature DB >> 10225546

Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingiva: implications for gingival overgrowth.

T T Myrillas1, G J Linden, J J Marley, C R Irwin.   

Abstract

BACKGROUND: Gingival overgrowth is a common side effect following the administration of cyclosporin A (CsA); however, the cellular mechanisms remain poorly understood. CsA's immunosuppressant properties involve the regulation of synthesis and cellular response to cytokines. A CsA-induced alteration in the cytokine profile within gingival tissue could provide a mechanism for gingival hyperplasia. The aim of this study was to investigate the effects of CsA on the production of 2 cytokines - interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) - by both gingival fibroblasts and peripheral blood mononuclear cells (PBMC).
METHODS: Cells were stimulated for 24 hours in the presence of CsA over a concentration range of 100 to 2,000 ng/ml and the resultant cytokine production determined by ELISA. In addition, levels of both cytokines within normal, inflamed, and overgrown gingival tissue were determined.
RESULTS: CsA inhibited IL-6 production by gingival fibroblasts in a dose-dependent manner. In contrast, at a concentration of 2,000 ng/ml, CsA stimulated IL-6 production by PBMC (P <0.05). Fibroblasts derived from overgrown gingiva produced significantly higher levels of IL-6 than their normal counterparts (P <0.05). CsA inhibited IL-1beta production by PBMC over the whole concentration range (P <0.05). IL-1beta was not found in measurable quantities in any of the fibroblast cultures. Levels of IL-6 extracted from overgrown gingival tissue were significantly higher than in inflamed or normal tissue. In contrast IL-1beta levels in overgrown tissue were not statistically significantly greater than those in inflamed tissue.
CONCLUSIONS: These results show that CsA does regulate cytokine expression in gingival tissue. This effect may play an important role in the pathogenesis of CsA-induced gingival overgrowth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225546     DOI: 10.1902/jop.1999.70.3.294

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  Efficacy of azithromycin and metronidazole combined therapy on rats' gingival overgrowth induced by cyclosporine-A: An experimental animal study.

Authors:  Mohammed Ali Elkabir; Rehab R El-Zehery; Mohamed I Mourad; Omar Soliman; Mohamed E Helal; Ali K Refai; Mohammed E Grawish
Journal:  J Oral Biol Craniofac Res       Date:  2016-04-05

Review 2.  Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth.

Authors:  Deepa Ponnaiyan; Visakan Jegadeesan
Journal:  Dent Res J (Isfahan)       Date:  2015 Nov-Dec

3.  Immunoexpression of interleukin-6 in drug-induced gingival overgrowth patients.

Authors:  P R Ganesh
Journal:  Contemp Clin Dent       Date:  2016 Apr-Jun

4.  Proliferative and inductive effects of Cyclosporine a on gingival fibroblast of child and adult.

Authors:  Bahareh Nazemi Salman; Surena Vahabi; Sepideh Ebrahimi Movaghar; Faranak Mahjour
Journal:  Dent Res J (Isfahan)       Date:  2013-01

5.  Efficacy of AZM therapy in patients with gingival overgrowth induced by Cyclosporine A: a systematic review.

Authors:  Marco Clementini; Gianluca Vittorini; Alessandro Crea; Maria Rosaria Gualano; Ludovica Antonella Macrì; Giorgio Deli; Giuseppe La Torre
Journal:  BMC Oral Health       Date:  2008-12-16       Impact factor: 2.757

6.  Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases.

Authors:  Haruna Hatahira; Junko Abe; Yuuki Hane; Toshinobu Matsui; Sayaka Sasaoka; Yumi Motooka; Shiori Hasegawa; Akiho Fukuda; Misa Naganuma; Tomofumi Ohmori; Yasutomi Kinosada; Mitsuhiro Nakamura
Journal:  J Pharm Health Care Sci       Date:  2017-07-19

7.  Drug-Induced Gingival Overgrowth: A Pilot Study on the Effect of Diphenylhydantoin and Gabapentin on Human Gingival Fibroblasts.

Authors:  Dorina Lauritano; Giulia Moreo; Luisa Limongelli; Elena Tregambi; Annalisa Palmieri; Francesco Carinci
Journal:  Int J Environ Res Public Health       Date:  2020-11-07       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.